Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DAROLUTAMIDE Cause Incorrect dose administered? 49 Reports in FDA Database

Prostate Health & Male Vitality — Naturally

ProstaVive: better flow, better sleep, better energy. 180-day guarantee.

Learn More

According to the FDA Adverse Event Reporting System (FAERS), 49 reports of Incorrect dose administered have been filed in association with DAROLUTAMIDE (NUBEQA). This represents 1.5% of all adverse event reports for DAROLUTAMIDE.

49
Reports of Incorrect dose administered with DAROLUTAMIDE
1.5%
of all DAROLUTAMIDE reports
3
Deaths
4
Hospitalizations

How Dangerous Is Incorrect dose administered From DAROLUTAMIDE?

Of the 49 reports, 3 (6.1%) resulted in death, 4 (8.2%) required hospitalization, and 2 (4.1%) were considered life-threatening.

Is Incorrect dose administered Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DAROLUTAMIDE. However, 49 reports have been filed with the FAERS database.

What Other Side Effects Does DAROLUTAMIDE Cause?

Fatigue (384) Death (361) Hot flush (203) Asthenia (173) Prostatic specific antigen increased (156) Off label use (133) Neuropathy peripheral (127) Diarrhoea (122) Dizziness (122) Rash (116)

What Other Drugs Cause Incorrect dose administered?

TIRZEPATIDE (23,301) ADALIMUMAB (14,000) DUPILUMAB (9,907) RANITIDINE (9,337) INSULIN LISPRO (8,318) ACETAMINOPHEN (5,316) DULAGLUTIDE (5,207) SECUKINUMAB (4,524) INSULIN GLARGINE (3,070) SOMATROPIN (2,772)

Which DAROLUTAMIDE Alternatives Have Lower Incorrect dose administered Risk?

DAROLUTAMIDE vs DARUNAVIR DAROLUTAMIDE vs DARUNAVIR ETHANOLATE DAROLUTAMIDE vs DARUNAVIR\RITONAVIR DAROLUTAMIDE vs DASABUVIR DAROLUTAMIDE vs DASABUVIR\OMBITASVIR HEMINONAHYDRATE\PARITAPREVIR\RITONAVIR

Related Pages

DAROLUTAMIDE Full Profile All Incorrect dose administered Reports All Drugs Causing Incorrect dose administered DAROLUTAMIDE Demographics